The Medicare Payment Advisory Commission yesterday issued its June report to Congress on refinements to Medicare payment systems and issues affecting the Medicare program, including broader changes in health care delivery and the market for health care services.

Topics include value-based payment and accountable care organizations; replacing the Medicare Advantage quality bonus program; the impact of 21st Century Cures Act changes to risk adjustment for Medicare Advantage enrollees; realigning incentives in Medicare Part D; separately payable drugs in the hospital outpatient prospective payment system; and improving Medicare’s end-stage renal disease prospective payment system.

The Medicaid and CHIP Payment and Access Commission also issued its June report to Congress yesterday.

Topics include how to better integrate care for beneficiaries who have both Medicaid and Medicare coverage; increasing enrollment in Medicare savings programs that use Medicaid funds to cover certain Medicare costs for low-income beneficiaries; Medicaid’s role in maternal health; and ensuring that Medicaid remains the payer of last resort when beneficiaries have other sources of coverage.

Related News Articles

Headline
An analysis by KFF released last week found that in 2022, Medicare spent 27% ($2,585) more, on average, for individuals covered by Traditional Medicare after…
Headline
A House Dear Colleague letter calling on House leadership to address scheduled Medicaid Disproportionate Share Hospital payment cuts received signatures from…
Headline
The AHA Dec. 9 said it supports a potential Medicare $2 Drug List Model, where people enrolled in a Part D plan would have access to certain prescription drugs…
Headline
In comments Dec. 9 to the Medicare Payment Advisory Commission, the AHA shared its views on physician fee schedule payments, advanced alternative payment model…
Headline
The Centers for Medicare & Medicaid Services Dec. 4 announced that drug manufacturers bluebird bio, inc. (manufacturer of Lyfgenia) and Vertex…
Headline
The Centers for Medicare & Medicaid Services Nov. 26 proposed changes to the Medicare Advantage and prescription drug programs for contract year 2026.…